TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Indevus Pharmaceuticals Case 01/16/2009

  • If you purchased a significant amount of shares of this company you have certain options and for certain investors are short and strict deadlines running. Investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

A shareholder of Indevus Pharmaceuticals Inc (NASDAQ: IDEV) has filed a lawsuit on behalf of investors in Indevus Pharmaceuticals Inc (NASDAQ: IDEV) in effort to prevent its sale to Endo Pharmaceuticals Inc (ENDP.O) for $370 million. The lawsuit alleges that the company and its directors breached their fiduciary duties by agreeing to the offer and merger at an inadequate price Las...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: